Per Lundin

Co-Founder & Chief Business Officer at Evox Therapeutics

Per has over 10 years of experience in advising, founding and leading biotech companies developing ground breaking therapies. Prior to co-founding Evox in 2016, he founded and led a cell therapy company, practiced patent law as a European Patent Attorney and worked in business development and consulting.

Links

Previous companies

Thomson Reuters logo

Timeline

  • Co-Founder & Chief Business Officer

    June, 2021 - present

  • Co-Founder & Chief Operating Officer

View in org chart